As CCR5 heterozygotes, who constituted the majority of Δ32-bearing patients, could potentially compensate for the impaired CCR5 expression by the upregulation of the CCL5 and other CCR5 ligands, the normal TBE presentations in them do not exclude the involvement of CCR5 signaling. The gene discussed is CCL5; the disease is tick-borne encephalitis.